|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,180.00 TWD | +0.43% |
|
-1.67% | +178.50% |
| 11:20am | PharmaEssentia Seeks Macau Nod to Expand Besremi Use for Rare Blood Cancer | MT |
| 09/07 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| Market Cap | 49TCr 1.5TCr 1.31TCr 1.22TCr 1.12TCr 2.11TCr 1,44700Cr 2.14TCr 15TCr 5.69TCr 71TCr 5.63TCr 5.51TCr 2,44600Cr | P/E 2026 * |
45.3x | P/E 2027 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 46TCr 1.42TCr 1.24TCr 1.15TCr 1.06TCr 2TCr 1,36800Cr 2.03TCr 14TCr 5.38TCr 67TCr 5.32TCr 5.21TCr 2,31300Cr | EV / Sales 2026 * |
18.3x | EV / Sales 2027 * | 13.1x |
| Free-Float |
75.37% | Yield 2026 * |
0.08% | Yield 2027 * | 0.12% |
| 1 day | +0.43% | ||
| 1 week | -1.67% | ||
| Current month | -2.32% | ||
| 1 month | +23.49% | ||
| 3 months | +101.38% | ||
| 6 months | +137.99% | ||
| Current year | +178.50% |
| 1 week | 1,170 |  | 1,365 |
| 1 month | 978.11 | | 1,415.34 |
| Current year | 423.7 | | 1,415.34 |
| 1 year | 395.61 | | 1,415.34 |
| 3 years | 222.58 | | 1,415.34 |
| 5 years | 56.05 | | 1,415.34 |
| 10 years | 43.54 | | 1,415.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Lih-Ling Lin
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -1.67% | +166.53% | +299.61% | 1.5TCr | |
| -0.43% | -1.26% | +52.13% | +85.69% | 5.56TCr | |
| -0.24% | +1.04% | +55.76% | +58.36% | 5.43TCr | |
| -0.61% | -0.21% | -17.63% | -14.23% | 2.33TCr | |
| -1.63% | -2.98% | +3.52% | +420.72% | 2.35TCr | |
| +0.05% | +1.68% | +38.71% | -4.57% | 2.03TCr | |
| +3.16% | +0.79% | +37.98% | -29.06% | 1.74TCr | |
| +1.08% | +3.77% | +36.92% | +593.96% | 1.56TCr | |
| -1.27% | -0.28% | +24.57% | +178.51% | 1.41TCr | |
| -1.34% | -1.50% | +72.94% | +163.52% | 1.26TCr | |
| Average | -0.07% | -0.02% | +47.14% | +175.25% | 2.52TCr | |
| Weighted average by Cap. | -0.17% | -0.13% | +45.19% | +139.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51TCr 77Cr 68Cr 63Cr 58Cr 108.86Cr 7.46TCr 110.46Cr 748.94Cr 293.13Cr 3.65TCr 290.13Cr 283.88Cr 13TCr | 3.46TCr 106.57Cr 93Cr 87Cr 80Cr 150.1Cr 10TCr 152.31Cr 1.03TCr 404.2Cr 5.03TCr 400.06Cr 391.44Cr 17TCr |
| Net income | 1.09TCr 33Cr 29Cr 27Cr 25Cr 47Cr 3.23TCr 48Cr 324.29Cr 126.93Cr 1.58TCr 125.63Cr 122.92Cr 5.46TCr | 1.5TCr 46Cr 40Cr 38Cr 35Cr 65Cr 4.45TCr 66Cr 447.3Cr 175.07Cr 2.18TCr 173.28Cr 169.54Cr 7.53TCr |
| Net Debt | -2.65TCr -82Cr -72Cr -67Cr -61Cr -115.18Cr -7.89TCr -116.88Cr -792.45Cr -310.16Cr -3.86TCr -306.99Cr -300.37Cr -13TCr | -3.47TCr -107.07Cr -94Cr -87Cr -80Cr -150.81Cr -10TCr -153.03Cr -1.04TCr -406.09Cr -5.06TCr -401.94Cr -393.27Cr -17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | NT$1,180.00 | +0.43% | 20,21,993 |
| 21/26/21 | NT$1,175.00 | 0.00% | 20,44,851 |
| 20/26/20 | NT$1,175.00 | -1.67% | 29,26,691 |
| 17/26/17 | NT$1,195.00 | -5.16% | 33,77,763 |
| 16/26/16 | NT$1,260.00 | -4.55% | 44,20,281 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
